Browse diseases

…Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality world…

… Tumors (mRECIST).Methods A total of 248 patients with advanced HCC were included in this study (from January 2022 to January 2025)…

…Background Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with limited effective …

…) is a standard first-line therapy for intermediate-to-advanced hepatocellular carcinoma (HCC), aiming to reduce tumor burden and prolong survival. Howe…

…gh-cholesterol diet (HFHCD), or DEN alone.Results In all murine HCC models, SLC26A6-OE mice exhibited significantly higher HCC inci…

…kground High recurrence rates following radical hepatectomy for hepatocellular carcinoma (HCC) remain a major clinical challenge. While postoperative ad…

…arkedly increased risk of hepatobiliary malignancies, including cholangiocarcinoma (HR 3.92; 95% CI: 2.75-5.59; p<0.001) and HCC (HR 4.01; 95% CI:…

…s.Methods We used UK Biobank data to determine whether incident CVD (the exposure; coronary heart disease [CHD], myocardial infarct…

…condary surgery for recurrent disease. In vivo, a C57BL/6 mouse HCC model mapped the 3D spatial distribution of hepatic nerves and …

…Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide, with po…

… remains a major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma across Asia. Despite the broad implementation of infant vaccina…

…n hepatocellular carcinoma (HCC). CD133/Prom1 marks a stem-like HCC population characterized by dedifferentiation toward an embryon…